A businessman accused of conspiring to smuggle prescription drugs into the U.S. through an India-based company admitted his guilt Monday in federal court in Pittsburgh.

Jeetendra Harish Belani, 37, an Indian national living in Mumbai, is an information technologist who ran a company called LeeHPL Ventures in India with a stated goal of being the top bulk prescription drug reseller in the world.

He pleaded guilty to three counts of conspiracy to import drugs from India to the Western District of Pennsylvania and launder money from the scheme with cohorts in the U.S.

Between 2015 and 2019, he admitted that he illegally imported Tapentadol, Tramadol, Carisoprodol, Etizolam and Modafinil to reshippers in the U.S. for distribution.

Advertise with us

In connection with the drug Etizolam, an anti-anxiety medication, he sold the drug through a website run by William Kulakevich and Julia Frees, who paid him by wire transfers or virtual currency, the U.S. attorney's office said.

To avoid getting caught, Belani and the others used false Customs declarations to hide the shipments and also shipped in small quantities in order to lessen suspicion.

Kulakevich, who lives in Alaska, pleaded guilty in the summer to his role in the scheme and was sentenced to eight months in federal prison.

Ms. Frees, who lives in Florida, has pleaded guilty and is awaiting sentencing.

Cases against two other accused co-conspirators are pending.